HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Disruption of SEMA4D ameliorates platelet hypersensitivity in dyslipidemia and confers protection against the development of atherosclerosis.

AbstractOBJECTIVE:
In dyslipidemic states, platelets become hyperreactive, secreting molecules that promote atherosclerosis. We have shown that the semaphorin family member, sema4D (CD100), is expressed on the surface of platelets and proposed that its role includes promoting thrombus growth by binding to nearby platelets and endothelial cells, both of which express sema4D receptors. Here we tested the hypothesis that deleting sema4D will attenuate the adverse consequences of dyslipidemia on platelets and the vessel wall.
METHODS AND RESULTS:
Platelet function and atherosclerotic lesion formation were measured in LDLR(-/-) and sema4D(-/-)LDLR(-/-) mice after 6 months on a high-fat diet. All of the mice developed the dyslipidemia expected on this diet in the absence of functional LDL receptors. However, when compared to LDLR(-/-) mice, sema4D(-/-) LDLR(-/-) mice had reduced lipid deposition in the descending aorta, a 6-fold decrease in the frequency of arterial occlusion and a reduction to near wild-type levels in the accumulation of platelets after injury. These differences were retained ex vivo, with a marked decrease in platelet accumulation on collagen under flow and in platelet aggregation.
CONCLUSIONS:
These results show that loss of sema4D expression reduces the platelet hyperactivity otherwise found in dyslipidemia, and confers protection against the development of atherosclerosis.
AuthorsLi Zhu, Timothy J Stalker, Karen P Fong, Hong Jiang, Anh Tran, Irene Crichton, Eric K Lee, Keith B Neeves, Sean F Maloney, Hitoshi Kikutani, Atsushi Kumanogoh, Ellen Pure, Scott L Diamond, Lawrence F Brass
JournalArteriosclerosis, thrombosis, and vascular biology (Arterioscler Thromb Vasc Biol) Vol. 29 Issue 7 Pg. 1039-45 (Jul 2009) ISSN: 1524-4636 [Electronic] United States
PMID19390055 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, CD
  • CD100 antigen
  • Semaphorins
Topics
  • Animals
  • Antigens, CD (physiology)
  • Aorta, Thoracic (pathology)
  • Atherosclerosis (blood, etiology, physiopathology)
  • Diet, Atherogenic
  • Hyperlipidemias (blood, complications, physiopathology)
  • Male
  • Mice
  • Mice, Knockout
  • Platelet Aggregation (physiology)
  • Semaphorins (physiology)
  • Thrombosis (physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: